The store will not work correctly when cookies are disabled.
5-Chloro-3-(3-methoxybenzamido)picolinic acid
ID: ALA4761682
PubChem CID: 162660622
Max Phase: Preclinical
Molecular Formula: C14H11ClN2O4
Molecular Weight: 306.70
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(C(=O)Nc2cc(Cl)cnc2C(=O)O)c1
Standard InChI: InChI=1S/C14H11ClN2O4/c1-21-10-4-2-3-8(5-10)13(18)17-11-6-9(15)7-16-12(11)14(19)20/h2-7H,1H3,(H,17,18)(H,19,20)
Standard InChI Key: LYYWPODAEPKLJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
35.0883 -2.6620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0871 -3.4816 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7952 -3.8905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5048 -3.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5020 -2.6584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7934 -2.2532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7950 -4.7077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0872 -5.1161 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.5026 -5.1165 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.2132 -3.8886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.9203 -3.4789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6286 -3.8864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9190 -2.6617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6253 -4.7020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3328 -5.1094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0408 -4.6996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0369 -3.8782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3288 -3.4745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7910 -1.4360 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
40.7425 -3.4660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.4523 -3.8710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 1 0
7 9 2 0
4 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 12 1 0
6 19 1 0
17 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 306.70 | Molecular Weight (Monoisotopic): 306.0407 | AlogP: 2.69 | #Rotatable Bonds: 4 |
Polar Surface Area: 88.52 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 0.92 | CX Basic pKa: 4.99 | CX LogP: 1.76 | CX LogD: -0.29 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.91 | Np Likeness Score: -1.55 |
References
1. Khalifa MM,Martorelli Di Genova B,McAlpine SG,Gallego-Lopez GM,Stevenson DM,Rozema SD,Monaghan NP,Morris JC,Knoll LJ,Golden JE. (2020) Dual-Stage Picolinic Acid-Derived Inhibitors of Toxoplasma gondii., 11 (12): [PMID:33335660] [10.1021/acsmedchemlett.0c00267] |